SCHEMBL804827

SCHEMBL804827

C[Si](C)(C)O[Si](C)(C)O[Si](C)(O[Si](C)(C)C)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20023890 0.98 ESR1 (0.33) ESR1ESR2
SCHEMBL1701835 0.98 ESR1 (0.35) ESR1ESR2
SCHEMBL21369184 0.96 ESR1 (0.34) ESR1ESR2
SCHEMBL2394267 0.91 ESR1 (0.39) ESR1ESR2
SCHEMBL17321847 0.90 ESR1 (0.31) ESR1ESR2
SCHEMBL2488130 0.89 ESR1 (0.38) ESR1ESR2
SCHEMBL2527239 0.89 ESR1 (0.38) ESR1ESR2
SCHEMBL21369181 0.88 ESR1 (0.31) ESR1ESR2
SCHEMBL15502089 0.88 ESR1 (0.34) ESR1ESR2
SCHEMBL14364092 0.88 ESR1 (0.32) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620068-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2006-02-01 EP claimed
WO-2004087077-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2004-10-14 WO claimed
US-20040197284-A1 Cosmetic composition comprising a volatile fatty phase L'OREAL S.A. (FR) 2004-10-07 US claimed
US-20240218293-A1 CLEANING AGENT COMPOSITION AND CLEANING METHOD NISSAN CHEMICAL CORPORATION (JP) 2024-07-04 US disclosed
EP-3558222-B1 WATER-IN-OIL EMULSION COMPRISING A PARTICULAR EMULSIFYING SYSTEM, A LIPOPHILIC CLAY, AND AN ORGANOPOLYSILOXANE ELASTOMER POWDER COATED WITH A SILICONE RESIN OREAL (FR) 2024-04-03 EP disclosed
US-11826443-B2 Solid cosmetic composition comprising a silicone polyamide, a silicone resin and a dispersed aqueous phase L'OREAL (FR) 2023-11-28 US disclosed
US-11819563-B2 Aqueous cosmetic composition comprising alkylcellulose L'OREAL (FR) 2023-11-21 US disclosed
US-20230355483-A1 TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION L'OREAL (FR) 2023-11-09 US disclosed
US-20230343629-A1 LAMINATE AND RELEASE AGENT COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2023-10-26 US disclosed
US-20230298923-A1 MULTILAYER BODY, RELEASE AGENT COMPOSITION, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE NISSAN CHEMICAL CORPORATION (JP) 2023-09-21 US disclosed
US-20230265325-A1 LAMINATE, RELEASE AGENT COMPOSITION, AND METHOD FOR MANUFACTURING PROCESSED SEMICONDUCTOR SUBSTRATE NISSAN CHEMICAL CORPORATION (JP) 2023-08-24 US disclosed
US-20080319121-A1 Room-Temperature Curable Organopolysiloxane Composition and Electrical or Electronic Devices DOW CORNING TORAY COMPANY, LTD. (JP) 2008-12-25 US disclosed
US-20080057297-A1 OPTICAL MULTI-LAYER SHEET AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2008-03-06 US disclosed
US-20070166247-A1 Method for improving moisturization and hydrating properties lip products CITICORP USA, INC. 2007-07-19 US disclosed
US-7208259-B2 Amino-functional fusing agent XEROX CORPORATION (US) 2007-04-24 US disclosed
US-20070036962-A1 NANO-COMPOSITE MATERIAL AND LIGHT EMITTING DEVICE SONY CORPORATION (JP) 2007-02-15 US disclosed
WO-2006013413-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE LINEAR ALKYLTRISILOXANE L'OREAL (FR) 2006-02-09 WO disclosed
EP-1620068-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2006-02-01 EP disclosed
WO-2004087077-A1 COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE L'OREAL (FR) 2004-10-14 WO disclosed
US-20040197284-A1 Cosmetic composition comprising a volatile fatty phase L'OREAL S.A. (FR) 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070166247-A1 Method for improving moisturization and hydrating properties lip products LIPA, LIPE, LPL ESR1 4610/4885ESR2 4750/4885
US-11819563-B2 Aqueous cosmetic composition comprising alkylcellulose CUTA, LIPC, H1-0 ESR1 3771/4885ESR2 4662/4885
US-11826443-B2 Solid cosmetic composition comprising a silicone polyamide, a silicone resin and a dispersed aqueous phase CUTA, POLR2H, POLD1 ESR1 1934/4885ESR2 2720/4885
US-20230355483-A1 TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION POLG, FFAR2, POLA1 ESR1 1598/4885ESR2 2038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.